Patents by Inventor Bonabes Olivier de Rouge

Bonabes Olivier de Rouge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7745575
    Abstract: OsK1 is a 38-residue peptide with 3 disulphide bridges and is found in the venom of the scorpion Orthochirus scrobiculosus. It is potently active on voltage-gated K+ channels Kv1.1, Kv1.2 and Kv1.3, and moderately active on the type 1 intermediate-conductance Cat2+-activated channel KCa3.1. Derivatives of OsK1, particularly involving truncation or point mutations, have been developed to enhance the activity against and selectivity for the Kv1.3 channel. This renders the derivatives likely candidates for the treatment of autoimmune diseases, including multiple sclerosis. Such use may be alone or in combination therapy with maurotoxin, another scorpion toxin.
    Type: Grant
    Filed: June 27, 2005
    Date of Patent: June 29, 2010
    Assignee: Cellpep Pharma Inc.
    Inventors: Stephanie Mouhat, Jean-Marc Sabatier, Bonabes Olivier de Rouge
  • Patent number: 6610304
    Abstract: The incorporation of multiple branch peptide constructions having activity against HIV into liposomes of sufficient size for white blood cell internalization (e.g. greater than 150 nm and preferably approximately 250-400 nm. ) has been shown to increase the activity of those MBPCs manifold. The liposomes and pharmaceutical compositions are described herein.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: August 26, 2003
    Inventor: Bonabes-Olivier de Rougé